Financing channel feed – Endpoints News

Financing channel feed

Bain leads big $70M round as Aptinyx plunges deeper into NMDA work

8 years ago

The 50 most active biotech VC funds in 2017

8 years ago

Jnana launches with $50M to spotlight an unexplored protein territory

8 years ago

Relay grabs $63M to pay for a drug discovery trip into the fourth dimension

8 years ago

Andreessen drums up a $450M fund to back their vision for engineering biology

8 years ago

Atlas and OrbiMed back Boston's Kyn in $49M round to pursue immunometabolism therapies

8 years ago

Yervoy inventor's oncology startup Pionyr gets $62M for tumor-fighting tech

8 years ago

Denali IPO hits a 2017 record $1.7B market valuation, raising $250M for neurodegeneration R&D

8 years ago

Sexual harassment in biotech hits home as OrbiMed’s Sam Isaly steps down in wake of STAT report

8 years ago

Rich Heyman's Metacrine grabs a $22M round in search of a superior NASH drug

8 years ago

Looking for the next big breakthrough in CAR-T, Mike Gilman debuts Obsidian with $49.5M round

8 years ago

Michael Pellini has just joined Bill Maris at Section 32 — focused on patient care and drug development

8 years ago

Atox Bio closes $30M round as it speeds through late-stage trials

8 years ago

Anti-aging startup ResTORbio gets $40M to fuel Phase IIb study

8 years ago

Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma

8 years ago

New backers Sofinnova and Scopia bring Y-mAb's round to $80M for anti-cancer drugs

8 years ago

Frazier backs MavuPharma’s $20M round, brings in heavyweight execs to lead

8 years ago

Doug Williams ups the ante at Codiak Bio to $168.5M in a drive to first human study

8 years ago

RA backs Medeor’s $57M round as researchers fast forward to PhIII

8 years ago

AstraZeneca teams with China-owned fund to launch a new biopharma drug development company

8 years ago

Six top biotech VCs take a look at the latest trends, and offer their thoughts on 2018

8 years ago

French upstart Step Pharma raises €8.6M, taking immunosuppressive drugs to the clinic

8 years ago

ScPharmaceuticals raises $90M in IPO with heart failure drug on deck

8 years ago

What's a successful failure? Atlas' Booth sounds taps for Merck-backed Quartet Medicine

8 years ago

First page Previous page 133 134 135136137 138 139 Next page Last page